Customize
Quick Links
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 22.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 22.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AbbVie Inc., Ariad Pharmaceuticals, Inc., Astellas, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Celgene, Foundation Medicine, Inc., Genentech, Lilly, Merck, Novartis Pharmaceuticals Corporation, and Pfizer.

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

17th Annual International Lung Cancer Congress®

17th Annual International Lung Cancer Congress®



Medical Crossfire®:Translating Recent Data Into Informed Sequencing Decisions in Advanced Non-Small Cell Lung Cancer

A CME/CE-certified satellite dinner symposium held adjunct to the 
17th Annual International Lung Cancer Congress®

Registration Fee - Free


Thursday, August 4, 2016
7:15 PM - 8:15 PM
Hyatt Regency Huntington Beach


Overview

"Medical Crossfire®: Translating Recent Data into Informed Sequencing Decisions in Advanced Non-Small-Cell Lung Cancer" is an ancillary symposium to the 17th Annual International Lung Cancer Congress®.

This interactive and dynamic session will aid physicians in assessing the wealth of new data, choosing treatment based upon patient and tumor characteristics, and applying those findings to their practices. This case-based activity will serve to update practitioners on advances in the field, with a particular focus on optimized advanced strategies for patients with non-small-cell lung cancer, practical information concerning how to assess response and when to switch therapies, and multidisciplinary methods to facilitate proactive management of treatment-related adverse effects. The activity will utilize a variety of formats, including presentation of new data, clinical scenarios exploring the evidence behind treatment decisions and adverse event management, and faculty Q&A to encourage peer-to-peer and peer-to-expert interactions, as well as, the sharing of best practices.

Educational Objectives

Upon completion of this activity, participants will be able to:

  • Review key concepts that inform front-line clinical decision-making in advanced NSCLC in the context of recent clinical trial evidence
  • Assess current and emerging testing methods to identify tumor characteristics that allow for personalized treatment strategies for patients with lung cancer
  • Discuss methods to monitor response in patients receiving treatment for advanced NSCLC
  • Review clinical trial evidence in NSCLC that informs decisions on the timing of treatment switching beyond disease progression
  • Summarize strategies to proactively plan for and manage treatment-related adverse events in patients with advanced NSCLC

Target Audience

This educational activity is directed toward oncologists, nurse practitioners (NPs), nurses, and physician assistants (PAs) involved in the treatment and management of patients with lung cancers. Pharmacists, researchers, fellows, and other healthcare professionals interested in the treatment of lung cancers may also participate.

Faculty

David R. Gandara, MD
Professor of Medicine
Division of Hematology/Oncology
Director, Thoracic Oncology Program
Senior Advisor to the Director
UC Davis Comprehensive Cancer Center
Sacramento, CA

Edward B. Garon, MD, MS
Associate Professor
Department of Medicine; Hematology-Oncology
David Geffen School of Medicine at UCLA
Los Angeles, CA

Suresh Ramalingam, MD
Professor
Chief of Thoracic Oncology
Director of Medical Oncology
Winship Cancer Institute of Emory University
Atlanta, GA

Giorgio Scagliotti, MD, PhD
Head, Department of Oncology
University of Torino
Orbassano (Torino), Italy

Agenda

Thursday, August 4, 2016
7:15 PM Welcome and Presession Survey David R. Gandara, MD
7:20 PM State of Advanced NSCLC Management in 2016: First-line Therapy Giorgio Scagliotti, MD, PhD
7:25 PM Advanced Squamous NSCLC in the Front-line Setting: Critical Decision Points David R. Gandara, MD; Edward B. Garon, MD, MS; Suresh Ramalingam, MD; Giorgio Scagliotti, MD, PhD
7:40 PM State of Advanced NSCLC Management in 2016: Second-line and Beyond David R. Gandara, MD
7:45 PM Advanced NSCLC Beyond Disease Progression: Critical Decision Points David R. Gandara, MD; Edward B. Garon, MD, MS; Suresh Ramalingam, MD; Giorgio Scagliotti, MD, PhD
8:10 PM Postsession Survey and Concluding Remarks David R. Gandara, MD
8:15 PM Adjourn David R. Gandara, MD


Accreditation/Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 1.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.







Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
Filter By